Strategic Planning

2.2. Actively pursue transdisciplinary research programs and extramural support

Trans disciplinary research depends upon faculty and program collaborations and funding. To advance this strategy the school will enhance efforts to communicate research initiatives to: encourage faculty interactions; catalogue faculty expertise and interests; and assist faculty, students and outside collaborators to identify areas of common interest and potential partnerships. Focused efforts will be devoted to developing high quality grants, major program initiatives, and research themes to enhance public and private funding support.

a. Develop mechanisms to promote collaboration internally and externally.

  • Offer departmental research seminars.
  • Leverage resources available within the school and university to fund interdisciplinary pilot projects and small grants.
  • Identify problems around which faculty can collaborate in the development of solutions.
  • Communicate discoveries to appropriate constituent groups.

b. Invest in graduate students to facilitate interdisciplinary collaboration.

  • Strengthen support available for graduate students to work in faculty labs.
  • Link graduate students through cross-campus affinity groups.
  • Support NIH training grant applications and administration.
  • Identify philanthropic funds to support graduate students.

c. Target programmatic grants.

  • Benchmark best practices in other schools and programs that have been successful at pursuing program project and center grants.
  • Provide staff support to facilitate program project grant submissions, either internally or by taking advantage of campus resources.

d. Develop a criteria-based process for assessing programmatic investments; consider the following as preliminary criteria:

  • Addresses an important societal need;
  • Supports a transdisciplinary approach;
  • Philanthropic or extramural support likely to be available;
  • Builds upon existing strength (leadership, faculty expertise, infrastructure, etc.);
  • Aligned with campus initiatives/priorities; and
  • Novel program that will differentiate the school.

e. Recruit faculty to develop and support identified themes.

f. Work with the Committee for Academic Personnel to ensure that collaborative research is recognized and rewarded in faculty promotions. a. Pursue research collaborations with schools and other organizations outside of UC Davis. (See Strategy 7.1)

Current Actions
  • Promoting New Collaborations & Opportunities
    Drs. M. Lairmore, D. Borjesson and J. Sykes led a team of school and campus representatives at the Animal Health Investment Forum in Kansas City August 29. This was a unique opportunity for venture capitalists, investment firms and animal health companies to hear about the newest technology and advances in animal health care.
  • Translational Research Success
    Congratulations to our research teams for their outstanding efforts to promote discovery. The School of Veterinary Medicine is once again leading the nation's veterinary schools in total Extramural Contracts and Grants funding at $56,603,665--$21million ahead of the second highest funded school (AAVMC Comparative Data Report 2015-16).
  • Philanthropy Supports Pioneering Research
    The Veterinary Institute for Regenerative Cures held an open house event on 11/4 to promote the many research developments and partnerships between the Schools of Medicine, Veterinary Medicine and College of Engineering. Dr. Borjesson acknowledged the major donors and CEH whose visionary contributions helped to create this forward looking research environment.
  • Leaders in Veterinary Regenerative Medicine - The multi-disciplinary team at the Veterinary Institute for Regenerative Medicine include faculty from across the SVM, as well as the School of Medicine, College of Engineering and College of Agricultural and Environmental Sciences. Together, this team has established laboratory techniques and animal models to study regenerative therapies in both veterinary and human medicine.  They've also developed "disease teams" that focus on "bench to bedside" translation of stem cell therapies. Check out the new VIRC web site.
  • Promoting Research and Education - The Center for Vector-borne Diseases recently launched its new web site. This multidisciplinary and collaborative center focuses on training and research to understand, prevent and manage vector-borne diseases. Educational programs provide opportunities for undergraduates, graduate students and post-docs. Current research themes include: vector-borne disease surveillance; ecology and evolution; host-pathogen interactions; computational biology; public health policy; and disease in conservation.
    Click here to visit the new CVEC website

  • Investing in Faculty and Resident Success - During this past year the Center for Companion Animal Health (CCAH) and the Center for Equine Health (CEH) have each provided significant support of faculty and resident studies. CCAH funded 46 Faculty Research Grants ($616,138), 9 Matching Funds Grants ($57,500), and 15 Resident Studies ($47,775). CEH provided $600,000 for Faculty Research Grants and $55,000 for Resident Studies. These key investments ensure the continuing success of our faculty and resident teams as well as the resulting advancements to animal health.
  • Translational Medicine - Changing Lives Video - In support of SVM faculty research endeavors in the area of translational medicine and specifically regenerative medicine, the following video was developed. This video will be used to demonstrate to various targeted audiences collaborative research, clinical trials, and translational medicine activities in progress here at the school. View video here.
  • Pioneers in Veterinary Genetics (pdf)
  • Center for Comparative Medicine Impacts (pdf)
Past Actions
  • Dedicated to Discovery
  • January Update
    Drs. Michael Kent, Robert Rebhun, Carlos Rodriguez and Katherine Skorupski were recently acknowledged by the Director of the Center for Cancer Research at the National Cancer Institute (NCI) for their efforts in the area of comparative oncology. Their unique and noteworthy scholarly contributions in the field of cancer drug development were particularly noted. Our colleagues have been collaborative members of the NCI’s Comparative Oncology Trial Consortium (COTC) which includes 20 veterinary schools across the U.S. and Canada. This is a great example of the collaborative efforts of our outstanding faculty, the recognition of their expertise at the national level and the impact of their efforts to advance translational research, the development of new oncology drugs/treatments, and the further promotion of our School’s national reputation.
  • Quarterly Report – October 2012 – Transdisciplinary Research (2.2.) Download pdf
  • Grant Writing Workshop Investments (March 2012) (Download PDF)